Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking

Stem Cells Translational Medicine

Volumn 3, Issue 5, 2014, Pages 586-598

  Tan, Hong Keetan ^a   Toh, Cheng Xu Delon ^a   Ma, Dongrui ^b   Yang, Binxia ^a   Liu, Tong Ming ^c   Lu, Jun ^b   Wong, Chee Wai ^a   Tan, Tze Kai ^a   Li, Hu ^d   Syn, Christopher ^e,f   Tan, Eng Lee ^g,h   Lim, Bing ^c,i   Lim, Yoon Pin ^j,k,l   Cook, Stuart A ^b,m,n,o   Loh, Yuin Han ^a,f  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

^d MAYO GRADUATE SCHOOL   (United States)

^e HEALTH SCIENCES AUTHORITY   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g SINGAPORE POLYTECHNIC   (Singapore)

^h NATIONAL UNIVERSITY HOSPITAL   (Singapore)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^k NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^l BIOINFORMATICS INSTITUTE   (Singapore)

^m DUKE NUS MEDICAL SCHOOL   (Singapore)

ⁿ ROYAL BROMPTON HOSPITAL   (United Kingdom)

^o NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

more..

Author keywords

Finger prick; Human induced pluripotent stem cell banking; Human peripheral blood; Induced pluripotent stem cells; Reprogramming

Indexed keywords

ARTICLE; BLOOD GROUP RH; BLOOD GROUP TYPING; CAPILLARY BLOOD; CELL CULTURE; DNA EXTRACTION; DNA FINGERPRINTING; DNA MICROARRAY; DNA SEQUENCE; FLOW CYTOMETRY; GENE EXPRESSION; GENOTYPE; HEALTH CARE FACILITY; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPING; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PLURIPOTENT STEM CELL BANK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEROTYPING; TERATOMA; VDJ RECOMBINATION; VENOUS BLOOD;

FINGER PRICK; HUMAN INDUCED PLURIPOTENT STEM CELL BANKING; HUMAN PERIPHERAL BLOOD; INDUCED PLURIPOTENT STEM CELLS; REPROGRAMMING;

BIOLOGICAL SPECIMEN BANKS; FEMALE; FINGERS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; REGENERATIVE MEDICINE; SPECIMEN HANDLING;

EID: 84899670989     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0195     Document Type: Article

References (42)

1. Takahashi K, Tanabe K, OhnukiMet al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
2. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
3. Park I-H, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451: 141-146.
4. Kondo T, Asai M, Tsukita K et al. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Ab and differential drug responsiveness. Cell Stem Cell 2013;12:487-496.
5. Park IH, Arora N, Huo H et al. Diseasespecific induced pluripotent stem cells. Cell 2008;134:877-886.
6. Loh YH, Agarwal S, Park IH et al. Generation of induced pluripotent stem cells from human blood. Blood 2009;113:5476-5479.
7. Ye Z, Zhan H, Mali P et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009;114:5473-5480.
8. Giorgetti A, Montserrat N, Aasen T et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009;5:353-357.
9. Haase A, Olmer R, Schwanke K et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 2009;5:434-441.
10. Sohn SK, Kim JG, Seo KW et al. GM-CSFbased mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2002;30:81-86.
11. Loh YH, Hartung O, Li H et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 2010;7:15-19.
12. Seki T, Yuasa S, OdaMet al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010;7:11-14.
13. Staerk J, Dawlaty MM, Gao Q et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010;7:20-24.
14. Serwold T, Hochedlinger K, InlayMAet al. Early TCR expression and aberrant T cell development in mice with endogenous prerearranged T cell receptor genes. J Immunol 2007; 179:928-938.
15. Chou BK, Mali P, Huang X et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011; 21:518-529.
16. Mack AA, Kroboth S, Rajesh D et al. Generation of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectors. PLoS One 2011;6:e27956.
17. Okita K, Yamakawa T, Matsumura Y et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. STEM CELLS 2013;31:458-466.
18. Merling RK, Sweeney CL, Choi U et al. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood 2013;121:e98-e107.
19. Ye L, Muench MO, Fusaki N et al. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. STEM CELLS TRANSLATIONAL MEDICINE 2013;2:558-566.
20. van den Akker E, Satchwell TJ, Pellegrin S et al. The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica 2010;95:1594-1598.
21. Yang W, Mills JA, Sullivan S et al. iPSC reprogramming from human peripheral blood using Sendai virus mediated gene transfer. StemBook 2012.
22. Freberg CT, Dahl JA, Timoskainen S et al. Epigenetic reprogramming of OCT4andNANOG regulatory regions by embryonal carcinoma cell extract. Mol Biol Cell 2007;18:1543-1553.
23. Prigione A, Fauler B, Lurz R et al. The senescence-relatedmitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. STEM CELLS 2010;28:721-733.
24. van Dongen JJ, Langerak AW, Brüggemann M et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17: 2257-2317.
25. Muro T, Fujihara J, Imamura S et al. Determination of ABO genotypes by real-time PCR using allele-specific primers. Leg Med 2012;14:47-50.
26. Simsek S, Faas BH, BleekerPMet al. Rapid Rh D genotyping by polymerase chain reactionbased amplification of DNA. Blood 1995;85: 2975-2980.
27. Chen WJ, Loh EW, Hsu YP et al. Alcohol dehydrogenase and aldehyde dehydrogenase genotypes and alcoholism among Taiwanese aborigines. Biol Psychiatry 1997;41:703-709.
28. Lian X, Hsiao C, WilsonGet al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 2012;109:E1848-E1857.
29. Muramatsu T, Higuchi S, Shigemori K et al. Ethanol patch test-a simple and sensitive method for identifying ALDH phenotype. Alcohol Clin Exp Res 1989;13:229-231.
30. Lensch MW, Schlaeger TM, Zon LI et al. Teratoma formation assays with human embryonic stem cells: A rationale for one type of human-animal chimera. Cell Stem Cell 2007;1: 253-258.
31. Taylor CJ, Peacock S, Chaudhry AN et al. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell 2012; 11:147-152.
32. Mölne J, Björquist P, Andersson K et al. Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte-and cardiomyocyte-like cells. Transplantation 2008;86:1407-1413.
33. Rao VR, Bhaskar LV, Annapurna C et al. Single nucleotide polymorphisms in alcohol dehydrogenase genes among someIndian populations. Am J Hum Biol 2007;19:338-344.
34. Xiao Q, Weiner H, Johnston T et al. The aldehyde dehydrogenase ALDH2*2 allele exhibits dominance over ALDH2*1 in transduced HeLa cells. J Clin Invest 1995;96: 2180-2186.
35. Rao M. Public private partnerships: A marriage of necessity. Cell Stem Cell 2013;12: 149-151.
36. Turner M, Leslie S, Martin NG et al. Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell 2013; 13:382-384.
37. Fusaki N, Ban H, Nishiyama A et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad, Ser B, Phys Biol Sci 2009;85:348-362.
38. Chen G, Gulbranson DR, Hou Z et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011;8: 424-429.
39. Zhou T, Benda C, Duzinger S et al. Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol 2011;22:1221-1228.
40. Xue Y, Cai X, Wang L et al. Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells. PLoS One 2013;8:e70573.
41. Cong L, Ran FA, Cox D et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013;339:819-823.
42. Geti I, Ormiston ML, Rouhani F et al. A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: Blood-derived endothelial progenitor cells. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:855-865.